Delivery Order SPE2DB24D2100-SPE2DB25FBEUY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,134.11 to supply Xhance 93 MCG nasal spray (16 mL units) with an ultimate completion date of September 18, 2025. This non-competitive delivery order utilizes firm fixed pricing and was awarded on September 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under a larger indefinite delivery contract...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product XHANCE 93 MCG NASAL SPRAY 16ML. The contract has a ceiling value of $1,026.39 and a period of performance through April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to deliver...
- The Defense Logistics Agency awarded a $1,212.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xhance 93 mcg nasal spray (16 mL). This firm fixed-price delivery order, which must be completed by August 11, 2025, represents a routine pharmaceutical procurement under the company's existing contract vehicle. The award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,463.62 order is for Xhance 93 mcg nasal spray and has a completion date of March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $583 to Amerisourcebergen Drug Corporation for XHANCE 93 mcg nasal spray. The prime contractor will deliver 16mL bottles of the nasal spray to a location in Conshohocken, Pennsylvania by August 1, 2023 in support of DLA programs. Amerisourcebergen will perform the order itself, as no subcontractors were identified. The Defense Logistics Agency manages the global supply chain for the U.S. military and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,294.97, is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML. It is a firm fixed-price contract with a period of performance ending on May 8, 2023. The contract was awarded on May 5, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of medical products including the medication XHANCE 93 MCG NASAL SPRAY 16ML. The contract has a ceiling value of $1,144.68 and a period of performance through April 15, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XHANCE 93 MCG Nasal Spray 16ML. The $4,796.97 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a wide range of medical commodities to support military treatment programs...
- This contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,770.87 firm fixed-price delivery order is for the drug product XHANCE 93 MCG Nasal Spray, 16 mL. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency awarded a $337,630 firm fixed price delivery order to AmerisourceBergen Drug Corporation for Xhance 93 mcg nasal spray. As part of its mission to support military readiness, the DLA procures pharmaceuticals and medical supplies through Prime Vendor contracts like the one held by AmerisourceBergen. This delivery order calls for 16ml bottles of the nasal spray to treat nasal polyps and is being fulfilled from AmerisourceBergen's facility in Conshohocken,...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBEUYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,855.22 to AmerisourceBergen Drug Corp for XHANCE 93 microgram nasal spray (16 milliliters) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive IDC vehicle enables it to supply a broad range of pharmaceutical products and medical supplies globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for XHANCE nasal spray reflects the contractor's role in fulfilling Defense Health Agency and broader federal healthcare requirements through the DLA Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 6/18/25 |